Fetal exposure to ACE inhibitors: congenital malformation risk?

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1106, 2006-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ACE inhibitors reduce CV risk in patients with atherosclerosis

By  

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Use of ACE inhibitors and risk of community-acquired pneumonia: a review

By Rafailidis Petros  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 565-573

Springer Publishing Company

Access to resources Recommend Favorite

Modern treatment of patients at risk: still a HOPE for ACE inhibitors?

By Angeli Fabio   Reboldi Gianpaolo   Verdecchia Paolo  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 6, 2011-04 ,pp. : 839-843

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular Risk in Patients with Early Renal Insufficiency: Implications for the Use of ACE Inhibitors

By Mann J.F.E.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 157-162

Adis International

Access to resources Recommend Favorite

In utero valproic acid exposure may increase risk of congenital disorders

By  

Inpharma, Vol. 1, Iss. 1485, 2005-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite